Overview
Belite Bio is a San Diego-based drug development company focused on degenerative retinal diseases with significant unmet medical need, such as Stargardt disease type 1 (STGD1) and geographic atrophy in advanced dry AMD. Its lead candidate, tinlarebant, is an oral therapy; the FDA accepted its New Drug Application for STGD1 with Priority Review and set a PDUFA target action date of February 12, 2027. Belite Bio is hiring its first US field sales team ahead of that decision.
Hiring snapshot
Hiring by specialty
Open roles
Newest first, from Belite Bio’s careers page.
- Regional Business Director (RBD)-SouthSan Diego, California9d ago$250k–$285k
- Regional Business Director (RBD)-WestSan Diego, California9d ago$250k–$285k
- Regional Business Director (RBD)-CentralSan Diego, California9d ago$250k–$285k
- Territory Business Manager - Denver-SLCDenver, Colorado9d ago$170k–$250k
- Territory Business Manager - Phoenix, AZPhoenix, Arizona9d ago$170k–$250k
- Territory Business Manager - Minneapolis, MNMinneapolis, Minnesota9d ago$170k–$250k
Divisions
Division information is pending company verification.Once Belite Bio claims its page, you will see each division, who it calls on and how it pays.
Claim your pageMore from Belite Bio
These sections fill in when Belite Bio claims and verifies its page.